Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Crohn disease (CD) and ulcerative colitis (UC) are increasingly common, chronic forms of inflammatory bowel disease. The behavior of these diseases varies unpredictably among patients. Identification of reliable prognostic biomarkers would enable treatment to be personalized so that patients destined to experience aggressive disease could receive appropriately potent therapies from diagnosis, while those who will experience more indolent disease are not exposed to the risks and side effects of unnecessary immunosuppression. Using transcriptional profiling of circulating T cells isolated from patients with CD and UC, we identified analogous CD8+ T cell transcriptional signatures that divided patients into 2 otherwise indistinguishable subgroups. In both UC and CD, patients in these subgroups subsequently experienced very different disease courses. A substantially higher incidence of frequently relapsing disease was experienced by those patients in the subgroup defined by elevated expression of genes involved in antigen-dependent T cell responses, including signaling initiated by both IL-7 and TCR ligation - pathways previously associated with prognosis in unrelated autoimmune diseases. No equivalent correlation was observed with CD4+ T cell gene expression. This suggests that the course of otherwise distinct autoimmune and inflammatory conditions may be influenced by common pathways and identifies what we believe to be the first biomarker that can predict prognosis in both UC and CD from diagnosis, a major step toward personalized therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CTLs are emerging as major mediators of human IBD, which is also prognostically linked to CTL profiling.31”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409
Huber, W., von Heydebreck, A., Sültmann, H., Poustka, A., & Vingron, M. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.suppl_1.s96 · Cited by 2,440
Research works printed but not linked: 2
- Fagan, 1975, N Engl J Med., 293, 257
- Muller, 1998, Am J Pathol., 152, 261
Cited by
Items 201–300 of 305
Chen, H., Li, P., Chen, J., Wang, Y., Yu, Q., Wu, Y., Chen, Y., & Cai, J. (2022) · The FASEB Journal · doi:10.1096/fj.202200452r · Cited by 9
A meta-analysis of expression signatures in glomerular disease
Tryggvason, S., Guo, J., Nukui, M., Norlin, J., Haraldsson, B. S., Jörnvall, H., Tryggvason, K., & He, L. (2013) · Kidney International · doi:10.1038/ki.2013.169 · Cited by 10
Association between TNF-αrs1799724 and rs1800629 polymorphisms and the risk of Crohn’s disease
Mao, Y. Q., Dong, S., & Gao, M. (2015) · Genetics and Molecular Research · doi:10.4238/2015.december.1.33 · Cited by 9
Biobanks and biomarkers: Their current and future role in biomedical research
Colwill, M., Baillie, S., Pollok, R., & Poullis, A. P. (2024) · World Journal of Methodology · doi:10.5662/wjm.v14.i4.91387 · Cited by 9
Chen, R., Li, C., Zheng, J., Fan, Z., Li, L., Chen, M., Chen, B., & Zhang, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1403420 · Cited by 10
Hamade, H., Tsuda, M., Oshima, N., Stamps, D. T., Wong, M. H., Stamps, J. T., Thomas, L. S., Salumbides, B. C., Jin, C., Nunnelee, J. S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1465175 · Cited by 8
Viewpoint: Toward the Genetic Architecture of Disease Severity in Inflammatory Bowel Diseases
Liefferinckx, C., & Franchimont, D. P. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy109 · Cited by 8
Dart, R., Ellul, P., Scharl, M. M., & Lamb, C. A. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab049 · Cited by 8
Ricciuto, A., Rauter, I., McGovern, D. P. B., Mader, R. M., & Reinisch, W. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.02.049 · Cited by 9
Ho, G., Boyapati, R. K., & Satsangi, J. (2015) · Medicine · doi:10.1016/j.mpmed.2015.02.004 · Cited by 8
Giachero, F., Jenke, A., & Zilbauer, M. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1945442 · Cited by 7
Biologic Therapy in Crohn’s Disease–What We Have Learnt So Far
Majchrzak, K., & Fichna, J. (2019) · Current Drug Targets · doi:10.2174/1389450121666191218123203 · Cited by 7
Dotson, J. L., & Boyle, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-67293-1.00042-6 · Cited by 8
Predicting outcomes for Crohn's disease using a molecular biomarker: profile trial
Noor, N. M., Brezina, B., Negro, J. D. L. R., Dowling, F., Bond, S. J., Whitehead, L., Lee, J., Lyons, P., McKinney, E. F., Smith, K. G. C., et al. (2022) · Clinical Medicine · doi:10.7861/clinmed.22-4-s22 · Cited by 7
Self-citationHave Genomic Discoveries in Inflammatory Bowel Disease Translated into Clinical Progress?
Weizman, A. V., & Silverberg, M. S. (2012) · Current Gastroenterology Reports · doi:10.1007/s11894-012-0248-6 · Cited by 8
Xiao, S., Xie, W., Zhang, Y., Pan, Y., & Lei, L. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13040571 · Cited by 6
Rodríguez–Lago, I., Blackwell, J., Mateos, B., Marigorta, U. M., Acosta, M. B., & Pollok, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103418 · Cited by 6
Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease
Chaparro, M., Aterido, A., Guerra, I., Iborra, M., Cabriada, J. L., Bujanda, L., Taxonera, C., García-Sánchez, V., Marín‐Jiménez, I., Acosta, M. B., et al. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819867848 · Cited by 6
Are We Ready to Reclassify Crohn’s Disease Using Molecular Classification?
Kamal, S., Parkash, N., Beattie, W., Christensen, B., & Segal, J. P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12185786 · Cited by 6
Exploring Predictive Biomarkers of Relapse in Ulcerative Colitis: A Proteomics Approach
Assadsangabi, A., Evans, C. A., Corfe, B. M., & Lobo, A. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad241 · Cited by 5
Rimmer, P. J., & Iqbal, T. H. (2023) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2023.101877 · Cited by 6
Bernard, J. K., Bucar, E. B., Liu, C. Y., Katada, K., Washington, M. K., Schumacher, M. A., & Frey, M. R. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad092 · Cited by 5
Lee, J. C. (2017) · HLA · doi:10.1111/tan.13170 · Cited by 4
Self-citationGonsky, R., Adams, E., Potdar, A. A., Botwin, G. J., Biener‐Ramanujan, E., McGovern, D. P. B., Braun, J. G., Fleshner, P. R., & Targan, S. R. (2023) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2023.1251133 · Cited by 4
Alsoud, D., Noor, N. M., Chen, L. A., Abadom, V., Anderson, S. H. C., Ardolli, L., Axelrad, J. E., Bossuyt, P. J., Croitoru, K., Damas, O. M., et al. (2025) · United European Gastroenterology Journal · doi:10.1002/ueg2.70050 · Cited by 4
Self-citationLinggi, B. E., Cremer, J., Wang, Z., van Viegen, T., Vermeire, S., Lefèvre, P. L. C., Shackelton, L. M., Jairath, V., Teft, W. A., Casteele, N. V., et al. (2023) · Journal of Immunological Methods · doi:10.1016/j.jim.2023.113504 · Cited by 4
Personalized Treatment in Inflammatory Bowel Disease: For Another Time
Kaneider, N. C., & Kaser, A. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.09.004 · Cited by 4
Validation of Predictive Models in Inflammatory Bowel Diseases
Kellermayer, R., & van der Laan, M. J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.11.005 · Cited by 4
Lee, J. C., Lyons, P., & McKinney, E. F. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.01.021 · Cited by 4
Self-citationRISK stratification in paediatric Crohn's disease
Arijs, I., & Cleynen, I. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30634-7 · Cited by 3
Edwards, S. J., Barton, S., Bacelar, M., Karner, C., Cain, P., Wakefield, V., & Marceniuk, G. (2021) · Health Technology Assessment · doi:10.3310/hta25230 · Cited by 3
There’s a goat behind door number 3: from Monty Hall to medicine
Friedman, D. J., Turka, L. A., & Robson, S. C. (2011) · Journal of Clinical Investigation · doi:10.1172/jci60003 · Cited by 3
Atreya, R. N., & Neurath, M. F. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab009 · Cited by 3
Shining a Light on Barrier Function
Friedrich, M., & Travis, S. P. L. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.11.023 · Cited by 3
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial
Satsangi, J. J., Nowak, J. K., Kalla, R., & Colombel, J. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00082-7 · Cited by 3
Recent developments in biomarker guided therapy for Crohn’s disease
Bargas, A., Torres, J., & Verstockt, B. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2590179 · Cited by 3
Therapeutic Dilemma in Personalized Medicine
Desoky, E. S. E. (2021) · Current Clinical Pharmacology · doi:10.2174/1574884716666210525153454 · Cited by 3
Deván, J., Nosi, V., Spagnuolo, J., Chancellor, A., Beshirova, A., Loureiro, J. P., Vacchini, A., Niess, J. H., Calogero, R., Mori, L., et al. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad098 · Cited by 2
Rejler, M., Füchtbauer, J. D., Davíðsdóttir, L. G., Fejrskov, A., Söderholm, J. D., Christensen, R., Andersen, V. C., Repsilber, D., Kjeldsen, J., Høivik, M. L., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-083163 · Cited by 2
Ge, C., Tong, Q.-Y., Zheng, S.-H., Liu, L., Tian, L., & Luo, H. (2025) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae120 · Cited by 3
Chromatin profiling to identify biomarkers in inflammatory bowel diseases
Awad, A., Alcala, A. J., Cowles, M. W., & Sheikh, S. Z. (2025) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001104 · Cited by 2
The future developments in inflammatory bowel disease care: Table 1
Irving, P. M. (2012) · Frontline Gastroenterology · doi:10.1136/flgastro-2011-100072 · Cited by 2
The Pediatric Crohn Disease Morbidity Index (PCD‐MI)
Ashton, J. J., Gurung, A., Davis, C., Seaby, E. G., Coelho, T. A. F., Batra, A., Afzal, N. A., Ennis, S., & Beattie, R. M. (2023) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003793 · Cited by 2
Personalised medicine for Crohn’s disease is a cost-effective strategyPreprint
Buchanan, V., Griffin, S. C., Tahir, W., Hills, K., Parkes, M., Smith, K. G. C., Lyons, P., Lee, J. C., & McKinney, E. F. (2022) · medRxiv · doi:10.1101/2022.12.01.22281309 · Cited by 2
Self-citationIBD Genomic Risk Loci and Overlap with Other Inflammatory Diseases
Hadizadeh, F., Lees, C. W., Labbé, C., Rioux, J. D., Parkes, M., Zhernakova, A., Franke, A., Hedin, C. R. H., & D’Amato, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-28703-0_5
Self-citationWilliams, S., Meran, L., McCartney, S. A., Harrow, P., & Lee, J. C. (2026) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaf222 · Cited by 1
Self-citationEpigenetic biomarkers in inflammatory bowel diseases—computational challenges and opportunities
Lee, S., Park, J., Lee, H. C., Xu, X., Slater, E., Gasparetto, M., Han, N., & Zilbauer, M. (2026) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjag022 · Cited by 1
Lee, Y., Kim, T., Kim, Y., Baek, J., Park, H., Yoon, D. K., Hwang, S. W., Lee, J. L., Park, S. H., Kim, J., et al. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01763-7 · Cited by 2
Self-citationTaking Crohn's Disease Personally
Chowers, Y. (2013) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10111 · Cited by 1
Guo, L., Li, Y. R., & Jin, X. (2015) · Genetics and Molecular Research · doi:10.4238/2015.august.28.20 · Cited by 1
Are Maintenance Strategies Underused in Crohn's Disease?
Rampton, D. S. (2014) · Digestive Diseases · doi:10.1159/000358145 · Cited by 1
Personalised medicine and genetic prediction – are we there yet?
Parkes, M. (2013) · Clinical Medicine · doi:10.7861/clinmedicine.13-6-s62 · Cited by 1
Self-citationPersonalising therapy: de‐escalation in Crohn's disease patients who are in deep remission
Sebastian, S. (2019) · GastroHep · doi:10.1002/ygh2.344 · Cited by 1
Molecular systems in inflammatory bowel disease
Pathan, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809356-6.00021-6 · Cited by 1
Genetic Risk Prediction in IBD
Marigorta, U. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-28703-0_7 · Cited by 1
Magro, F., Sottomayor, C., Alves, C., Santiago, M., Ministro, P., Lago, P. M., Correia, L., Gonçalves, R., Carvalho, D., Portela, F., et al. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221092754 · Cited by 1
Lin, W., Kartawinata, M., Jebson, B. R., Restuadi, R., Peckham, H., Radziszewska, A., Deakin, C. T., Ciurtin, C., Wedderburn, L. R., & Wallace, C. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012859 · Cited by 1
Molecular Profiling of IBD Subtypes and Therapy Responses
Lee, H., & Cleynen, I. (2019) · Springer eBooks · doi:10.1007/978-3-030-28703-0_8 · Cited by 1
Hawthrone, A. B. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13400 · Cited by 1
Pathophysiological and clinical studies on Crohn's disease in children
Ideström, M. (2012) · Figshare · Cited by 1
CD8+ T-cell responses in a Th2-polarized inflammatory setting
Kurzweil, V. (2013) · ScholarlyCommons (University of Pennsylvania)
Patient stratification and genomics: flares, fizzlers and foxes
Smith, K. G. C. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-s3-i5
Self-citationRepublished: Recent advances: personalised use of current Crohn’s disease therapeutic options
Vermeire, S., Ferrante, M., & Rutgeerts, P. J. (2014) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2012-303958rep
Towards Personalized Therapy in Inflammatory Bowel Disease
McGovern, D. P. B. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8256-7_16
Chronisch-entzündliche Darmerkrankungen
Siegmund, B. (2012) · Der Pathologe · doi:10.1007/s00292-012-1641-5
Update zu chronisch entzündlichen Darmerkrankungen: Neues zur Pathogenese und Therapie bei CED
Adolph, T. E., & Tilg, H. (2016) · Wiener klinisches Magazin · doi:10.1007/s00740-016-0124-3 · Cited by 1
Efeito da amitriptilina em um modelo murino de colite
Namazu, L. B. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.10.2016.tde-27082015-152949
Crohn's disease for the general physician: management
Barlow, J., & Hawthorne, A. (2017) · British Journal of Hospital Medicine · doi:10.12968/hmed.2017.78.2.77
Parkes, M. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14416
Self-citationOne Size Does Not Fit All: The Case for Translational Medicine
Chowers, Y. (2019) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10364
Innate and Adaptive Immunology
Noor, N. M., & Raine, T. (2019) · Springer eBooks · doi:10.1007/978-3-030-11446-6_26
Genetic and Genomic Markers for Prognostication
Noor, N. M., Parkes, M., & Lee, J. C. (2019) · Springer eBooks · doi:10.1007/978-3-030-11446-6_27
Self-citationGeneral Discussion and Future Perspectives
Cassarini, C. (2019) · CRC Press eBooks · doi:10.1201/9780429448300-7
Toward Personalized Therapy in Inflammatory Bowel Disease
Ungaro, R. C., & Colombel, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-28703-0_17
Singh, A. (2019) · Journal of International Crisis and Risk Communication Research
Ströbaek, J. (2019) · University Library of Skövde (University of Skövde)
PredictImmune: a blood test to tailor treatment for bowel condition
Dolgin, E. (2020) · Nature · doi:10.1038/d41586-020-01804-9
Precision Medicine: Predicting Disease Course in Patients with Inflammatory Bowel Disease
Rao, B. B., Bhattacharya, A., & Lichtenstein, G. R. (2020) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-020-00307-w
Zilbauer, M., & Heuschkel, R. B. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.01.212
A blood-based prognostic biomarker in inflammatory bowel diseasePreprint
Biasci, D., Lee, J. C., Noor, N. M., Pombal, D., Lewis, N. R., Ahmad, T., Hart, A. L., Parkes, M., McKinney, E. F., Lyons, P. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/535153 · Cited by 1
Self-citationFaculty Opinions recommendation of A blood-based prognostic biomarker in IBD.
Satsangi, J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735622905.793569695
Spicuglia, S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737669738.793580246
Questions to consider when caring for patients with ulcerative colitis
Hasselblatt, P., Reindl, W., Gauss, A., Neeff, H. P., Fusco, S., & Klaus, J. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1890-6015
Luan, Y., Hu, J., Wang, Q., Li, W., Wang, X., Qu, R., Rajendran, B. K., Zhou, H., Liu, P., Shi, Y., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.28.526056
Cheah, E., & Huang, J. G. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i10.1395
Liu, Y., Fang, S., Chen, P., Sun, J., Wang, B., & Liu, Q. (2023) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.spl.674
Role of CD169 macrophages in cellular adaptive immune responses
Mauvais, F. (2016) · theses.fr (ABES) · doi:10.70675/a63cfe0cza36bz4b48z8a34zf880c078dc68
Mishra, N., Aden, K., Blase, J. I., Baran, N., Bordoni, D., Tran, F., Conrad, C. C., Avalos, D., Jaeckel, C., Scherer, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21203361
Self-citationEtude du rôle de SMAD4 dans les lymphocytes T CD8+ au niveau de la muqueuse intestinale
Igalouzene, R. (2021) · theses.fr (ABES) · doi:10.70675/865faa7dz9a5fz44f7z965ez46d7cc4262d9
PROFILE: Top-down treatment strategy benefits patients with early Crohn’s disease
van den Heuvel, R. (2024) · doi:10.55788/95adec97
Avancées dans le diagnostic biologique des maladies inflammatoires chroniques de l’intestin
Carlé, C., Bost, C., Cosquer, G. L., & Fortenfant, F. (2024) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(24)00176-x
Additional file 3 of Altered splicing associated with the pathology of inflammatory bowel disease
Berger, K., Somineni, H., Prince, J., Kugathasan, S., & Gibson, G. C. (2021) · Figshare · doi:10.6084/m9.figshare.15047941
Mishra, N., Aden, K., Blase, J. I., Baran, N., Bordoni, D., Tran, F., Conrad, C., Avalos, D., Jaeckel, C., Scherer, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21203364
Self-citationAdditional file 4 of Altered splicing associated with the pathology of inflammatory bowel disease
Berger, K., Somineni, H., Prince, J., Kugathasan, S., & Gibson, G. C. (2021) · Figshare · doi:10.6084/m9.figshare.15047944
Molecular Profiling of IBD Subtypes/Response to Therapy
Cleynen, I., & Vermeire, S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8256-7_8
Impact de l'inflammation intestinale sur la dynamique et la fonction des lymphocytes T régulateurs
Boschetti, G. (2016) · theses.fr (ABES) · doi:10.70675/88c2556cz80e4z4822z9448zbf8db6b1c051
Metadata
- Authors
- Lee, J. C., Lyons, P. A., McKinney, E. F., Sowerby, J. M., Carr, E. J., Bredin, F., Rickman, H. M., Ratlamwala, H., Hatton, A., Rayner, T. F., Parkes, M., & Smith, K. G. C.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Smith, Kenneth G.C.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-10-03
- Volume
- 121
- Issue
- 10
- Pages
- 4170-4179
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3196314
- OpenAlex
- W2015008025
- Cited by
- 304
- References
- 58
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 15 · 2023: 30 · 2022: 29 · 2021: 27 · 2020: 28 · 2019: 40 · 2018: 10 · 2017: 18 · 2016: 21 · 2015: 22 · 2014: 17 · 2013: 16 · 2012: 17
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust (083650/Z/07/Z, 079895/Z/06/Z, 079895, 079895/Z/06/B)
- Crohn's and Colitis UK (M09-2)
- Medical Research Council
- Cambridge Institute for Medical Research, University of Cambridge (079895)
- NIHR Cambridge Biomedical Research Centre
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- Crohn's disease, ulcerative colitis, inflammatory bowel disease, CD8+ T cells, gene expression profiling, prognostic factors, recurrence, IL-7 signaling, T cell receptor signaling, CD4+ T cells, personalized treatment
- MeSH terms
- Adult, Colitis, Ulcerative, Crohn Disease, Female, Humans, Male, Middle Aged, Prognosis, Prospective Studies, Receptors, Antigen, T-Cell, Signal Transduction, Interleukin-7, CD8-Positive T-Lymphocytes, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.